Robotics Stocks to Buy: Ekso Bionics (EKSO)
Let’s face it: Microcaps are not for the faint of heart — and Ekso Bionics (EKSO) is no exception.
But if you’ve got a high tolerance for risk (or were a fan of the 1970’s series The Six Million Dollar Man), this stock with a plan to make the mobility-challenged “better, stronger and faster” could find a home in your portfolio.
Since 2005, Ekso Bionics has been focused on developing robotic exoskeletons to augment human strength, endurance and mobility.
Specifically, Ekso focuses on “wearable bionics” — suits that enable an individual with any amount of lower extremity weakness to stand up and walk over ground with a natural, full-weight bearing, reciprocal gait. The user is able to walk as his/her weight shifts, activating sensors in the device that initiate steps. The legs are driven by battery-powered motors that effectively replace lost neuromuscular function.
While Ekso’s bionic suit won’t enable a modern-day “Steve Austin” leap high fences or run 60 miles per hour, it gives even a completely paralyzed individual with minimal arm strength the ability to stand and walk. And that’s no minor miracle.
Ekso has forged partnerships with institutions like UC, Berkeley, received research grants from the Department of Defense and licensed technology to Lockheed Martin (LMT). Plus, U.S. Special Operations Command recently gave Ekso a prototype grant to develop technologies for their Tactical Assault Light Operator Suit project — a futuristic assault suit (nicknamed the “Iron Man” suit) that promises to provide superhuman strength with superior mobility and protection.
For investors who dream of buying into a real-life version of Tony Stark’s company, sinking a little mad money into EKSO stock could be hard to resist.
Just remember: Bleeding-edge technologies like wearable robotics are a high-risk, high-reward play.
As of this writing, Susan J. Aluise did not hold a position in any of the aforementioned securities.